EGFR and lung adenocarcinoma: El Zarif et al. developed for the first time a non-invasive approach to detect small cell transformation (tSCLC) by epigenomic profiling of 1 mL of plasma in patients with EGFR-mutated lung adenocarcinoma progressing to EGFR-TKIs.